Benzinga Newsdesk, Author at Spark Newswire

5 minute read

June 20, 8:39 AM

Dear shareholders:2024 is a transformational year for AgriFORCE. Since inception, it has focused on innovation within the agriculture industry, primarily through patenting new technology or seeking to acquire or partner

AGRI

1 minute read

Jabil Reiterated FY24 Revenue of $28.5B Vs $28.49B Est, Adj EPS of $8.40 Vs $8.37 Est

By Benzinga Newsdesk

June 20, 7:51 AM

Fiscal Year 2024 Outlook: • Net revenue $28.5 billion • Core operating margin

JBL

1 minute read

Jabil Expects Q4 Revenue of $6.3B-$6.9B Vs $6.8B Est, Adj EPS of $2.03-$2.43 Vs $2.22 Est

By Benzinga Newsdesk

June 20, 7:48 AM

Fourth Quarter of Fiscal Year 2024 Outlook: • Net revenue $6.3 billion to $6.9 billion • U.S. GAAP operating

JBL

1 minute read

News

Oncolytics Biotech Begins New Study for Advanced Pancreatic Cancer Treatment

By Benzinga Newsdesk

June 20, 7:28 AM

SAN DIEGO, and CALGARY, AB, June 20, 2024 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ:ONCY) (TSX:ONC), a leading clinical-stage company specializing in immunotherapeutics for oncology,

ONCY

1 minute read

News

SAB Biotherapeutics Rebrands as SAB BIO, Focuses on Type 1 Diabetes Therapies

By Benzinga Newsdesk

June 20, 7:24 AM

SAB Biotherapeutics (NASDAQ:SABS) (the "Company" or "SAB"), a clinical-stage biopharmaceutical company with a novel immunotherapy platform developing a human anti-thymocyte immunoglobulin (hIgG) for

SABS

1 minute read

News

Altair Joins S&P MidCap 400, Marking Significant Growth Milestone

By Benzinga Newsdesk

June 20, 7:03 AM

Altair (NASDAQ:ALTR), a global leader in computational intelligence, was added to the S&P MidCap 400 by S&P Dow Jones Indices effective prior to the open of trading on Monday, June

ALTR

3 minute read

News

Neumora Initiates Phase 1b Trial for Alzheimer’s-Related Agitation Treatment

By Benzinga Newsdesk

June 20, 7:02 AM

Neumora Therapeutics, Inc. (Neumora), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven clinical and pre-clinical brain disease programs, today announced the initiation of a

NMRA

2 minute read

News

Palantir Secures $19M ARPA-H Contract to Boost Health Outcomes with AI

By Benzinga Newsdesk

June 20, 7:01 AM

Palantir Technologies Inc. (NYSE:PLTR) today announced that it has been selected by the Advanced Research Projects Agency for Health (ARPA-H) to support the agency's mission to accelerate better health outcomes.

PLTR

1 minute read

News

AECOM to Lead Design for Washington’s SR 520 Portage Bay Bridge Project

By Benzinga Newsdesk

June 20, 7:00 AM

AECOM (NYSE:ACM), the world's trusted infrastructure consulting firm, today announced it will serve as Lead Designer for the Washington State Department of Transportation's (WSDOT) SR 520 Portage Bay Bridge and

ACM

1 minute read

News

Piedmont Lithium Uncovers High-Grade Lithium Zones in Quebec, New Drill Results Boost Piedmont Lithium’s Resource Potential at NAL

By Benzinga Newsdesk

June 20, 6:55 AM

Piedmont Lithium ("Piedmont" or the "Company") (NASDAQ:PLL, ASX: PLL)))), a leading North American supplier of lithium products critical to the U.S. electric vehicle supply chain, today announced

PLL